Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Avant Diagnostics, Inc (OREO)
|
Add to portfolio |
|
|
|
| Price: |
$0.01
| | Metrics |
| OS: |
337.0
|
M
| |
-136
|
% ROE
|
| Market cap: |
$2.36
|
M
| |
-132
|
% ROIC
|
|
Net debt:
|
$226.8
|
k
| |
|
|
|
EV:
|
$2.59
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($2.1)
|
M
| |
|
|
|
EBIT
|
($2.5)
|
M
| |
|
|
| EPS |
($0.01)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 | Oct-31-14 | Sep-30-14 | Oct-31-13 | Oct-31-12 |
| Revenues | 0.0 | 0.3 | 0.1 | 2.0 | 0.0 | 0.0 | 0.0 | -1.4 |
| Revenue growth | -100.0% | 116.8% | -94.1% | | | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.1 | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.2 | 0.1 | 2.7 | 0.0 | 0.0 | 0.0 | -1.4 |
| Gross margin | | 89.2% | 55.5% | 135.1% | | | | 100.0% |
| Selling, general and administrative | 2.3 | 8.6 | 1.5 | 0.7 | | 0.5 | | |
| Research and development | | | | 0.0 | | | | |
| General and administrative | 0.9 | 6.0 | 0.3 | 0.1 | 0.0 | | 0.3 | 0.6 |
| EBIT | -2.3 | -8.3 | -1.5 | 0.7 | 0.0 | 0.0 | -0.3 | -2.0 |
| EBIT margin | | -3252.1% | -1252.8% | 32.8% | | | | 141.6% |
| Pre-tax income | -2.4 | -9.6 | -11.8 | -3.3 | 0.0 | 0.5 | -0.3 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 200.0% | 0.0% | |
| Net income | -2.4 | -9.6 | -11.8 | -3.3 | 0.0 | -0.5 | -0.3 | -2.0 |
| Net margin | | -3745.2% | -9961.9% | -167.2% | | | | 141.6% |
| |
| Diluted EPS | ($0.01) | ($0.05) | ($0.08) | ($0.04) | $0.00 | ($0.01) | $0.00 | ($0.02) |
| Shares outstanding (diluted) | 240.7 | 200.2 | 146.2 | 85.8 | 107.4 | 50.2 | 107.1 | 105.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|